Results 261 to 270 of about 991,885 (339)
Strand-selective repair of DNA damage in the yeast GAL7 gene requires RNA polymerase II
Steven A. Leadon, David A. Lawrence
openalex +1 more source
Chronic wounds remain a major therapeutic challenge, with VEGF applications hindered by rapid degradation and systemic side effects. Here, a dual‐responsive chitosan–gelatin hydrogel is reported, functionalized with dopamine, glutathione, and MMP‐sensitive motifs, enabling spatiotemporally controlled VEGF release and enhanced biocompatibility, thereby ...
Zhenghui Xiong +5 more
wiley +1 more source
3D‐Printed Unibody Microfluidic Devices for Organ‐on‐Chip Applications
A practical approach is demonstrated to 3D printing unibody microfluidic Organ‐on‐Chip (OoC) devices using commercial resins and desktop DLP printers. The demonstrated functional devices support 2D monolayers, 3D spheroids, and barrier tissues. With optimised design and post‐processing techniques, leak‐free, biocompatible microchannels and membranes ...
Louis Jun Ye Ong +8 more
wiley +1 more source
The transcription factor IID subunit Taf13 is dispensable for TATA binding protein promoter recruitment and RNA polymerase II transcription. [PDF]
Martianov I +3 more
europepmc +1 more source
Implementation of FTA Elute Card for Viral RNA Storage and Cost‐Effective Wastewater Surveillance
A strategy is developed for room‐temperature storage of RNA from wastewater using FTA Elute cards, which allow for easy and portable transportation. FTA Elude cards provided a 15.4% recovery of the original RNA with cards, compared to only 0.5% recovery without cards.
Qingxin Hui +3 more
wiley +1 more source
Mechanisms of transcription attenuation and condensation of RNA polymerase II by RECQ5
Sebesta M +10 more
europepmc +1 more source
Spt6-Spn1 interaction is required for RNA polymerase II association and precise nucleosome positioning along transcribed genes. [PDF]
Chen B +9 more
europepmc +1 more source
Cyclodextrin nanoparticle containing both Ga(NO3)3 and GaPP is synthesized and tested against non‐tuberculous mycobacteria (NTM). The in vivo efficacy of the nanoparticle therapy is additionally tested by treating pulmonary NTM infections in mice and observed much greater effectiveness in bacterial clearance and survival of mice.
Seoung‐ryoung Choi +2 more
wiley +1 more source

